// App-Quantinova.ai

1304 : The effect of FoxM1 inhibition with thiostrepton on ovarian cancer immune response and sensitivity to chemotherapy in vitro

Researchers

Presenter

  • Jill Madden

Principal Investigators

  • Pingping Fang

  • Bernard Herrman

  • Mary Markiewicz

  • Ryan Moulder

  • Laird Forrest

  • Jeremy Chien

Medical Centers

  • Department of Microbiology, University of Kansas Medical Center, Kansas City, KS

  • Department of Microbiology, University of Kansas Medical Center, Kansas City, KS

  • Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-grade serous carcinoma

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • Thiostrepton

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved